Anatomy of a Headache

Dr. Robbins Free Medical
Radio Podcasts

Long-Acting Opioids for
Refractory Chronic

Study results for a group
of difficult-to-treat
migraineurs provide a
basis for determining
efficacy and guidelines
for the use of long-term
opioids in this


Heatherís Chronic
Migraine: an Interactive
Case History

This column will take you,
step by step, through
the diagnosis of a complex
headache patient with
the pseudonym of "Heather."



60 Revere Drive, Suite 330, Northbrook, IL 60062
Phone: 847-480-9399

Current Practice and Future Directions In The Prevention and Acute Management of Migraine
Goadsby, PJ, Sprenger T.
Posted: March 2010
Lancet Neurology  22010 Mar;9(3):285-298

Migraine is a common and disabling brain disorder with a strong inherited component. Because patients with migraine have severe and disabling attacks usually of headache with other symptoms of sensory disturbance (eg, light and sound sensitivity), medical treatment is often required. Patients can be managed by use of acute attack therapies (eg, simple analgesics or non-steroidal anti-inflammatory drugs) or specific agents with vasoconstrictor properties (ie, triptans or ergot derivatives). Future non-vasoconstrictor approaches include calcitonin gene-related peptide receptor antagonists. Preventive therapy is probably indicated in about a third of patients with migraine, and a broad range of pharmaceutical and non-pharmaceutical options exist. Medication overuse is an important concern in migraine therapeutics and needs to be identified and managed. In most patients, migraine can be improved with careful attention to the details of therapy, and in those for whom it cannot, neuromodulation approaches, such as occipital nerve stimulation, are currently being actively studied and offer much promise.

Home | About Us | Archives & Topical Index | Doctors' Blog |Headache Books | Links | Search

Copyright © 2002-  Lawrence Robbins, MD
All Rights Reserved.
This site is maintained by MICE Creative Services   Contact: